Bio-Techne (TECH) Q1 2025 Earnings
Bio-Techne reported Q1 2025 revenue of $316.2M (+4.2% YoY), missed analyst consensus of $325.5M by $9.3M. Diluted EPS came in at $0.56 (+16.7% YoY), beat the $0.51 consensus by $0.05.
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Bio-Techne's Q1 2025 earnings report.
Bio-Techne (TECH) reported Q1 2025 earnings on May 7, 2025 before market open.
Bio-Techne reported revenue of $316.2M and diluted EPS of $0.56 for Q1 2025.
Revenue missed the consensus estimate of $325.5M by $9.3M. EPS beat the consensus estimate of $0.51 by $0.05.
Compared to the same quarter a year prior, revenue grew 4.2% from $303.4M a year earlier and diluted EPS grew 16.7% from $0.48.
You can read the 10-Q periodic report (0001558370-25-006990) directly on SEC EDGAR. The filing index links above go to sec.gov.